Prognosis of low-flow low-gradient aortic valve stenosis with atrial fibrillation

Ryo Nishinarita1, Jun Oikawa2, Kenshiro Arao1

  • 1Department of Cardiovascular Medicine, Nerima Hikarigaoka Hospital, Nerima, Japan.

Journal of Cardiology
|April 4, 2025
PubMed

Insights

Patients with low-flow low-gradient aortic valve stenosis and atrial fibrillation face a higher risk of heart failure. Atrial fibrillation is an independent predictor of worsening heart failure in this population.

Area of Science:

  • Cardiology
  • Valvular Heart Disease
  • Heart Failure Research

Background:

  • The prognosis for patients with low-flow low-gradient aortic valve stenosis (LFLG AS) is debated.
  • Atrial fibrillation (AF) is a known factor in low-flow status for severe AS (SAS).
  • The link between AF and heart failure (HF) risk in LFLG AS is not well understood.

Purpose of the Study:

  • To investigate the association between concomitant atrial fibrillation (AF) and the risk of worsening heart failure (HF) in patients with low-flow low-gradient aortic valve stenosis (LFLG AS).
  • To compare the risk of HF worsening in LFLG AS patients with and without AF against high-gradient AS (HG SAS) patients.

Main Methods:

  • Evaluated 278 patients with severe AS (SAS), categorizing them into high-gradient (HG) and low-flow low-gradient (LFLG) AS groups.
  • Subdivided groups based on the presence or absence of atrial fibrillation (AF).
  • Primary endpoint: worsening HF requiring hospitalization or specific drug therapy.

Main Results:

  • Worsening HF observed in 65 patients.
  • LFLG AS with AF showed a significantly higher rate of HF worsening compared to HG SAS without AF.
  • AF was identified as an independent predictor for worsening HF in LFLG AS patients (HR: 2.79; p=0.021).

Conclusions:

  • Patients with LFLG AS and concurrent AF have an unfavorable prognosis regarding HF.
  • The rate of HF worsening in LFLG AS with AF is comparable to that in HG SAS with AF.
  • Concomitant AF significantly increases the risk of worsening HF in LFLG AS patients.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...